Green tea consumption and hematologic malignancies in Japan the ohsaki study

American Journal of Epidemiology

Volumn 170, Issue 6, 2009, Pages 730-738

  Naganuma, Toru ^a   Kuriyama, Shinichi ^a   Kakizaki, Masako ^a   Sone, Toshimasa ^a   Nakaya, Naoki ^a,b   Ohmori Matsuda, Kaori ^a   Hozawa, Atsushi ^a   Nishino, Yoshikazu ^c   Tsuji, Ichiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Catechin; Cohort studies; Hematologic neoplasms; Japan; Risk; Tea

Indexed keywords

ADULT; FOOD CONSUMPTION; FOOD SAFETY; HEALTH RISK; HEMATOLOGY; MULTIVARIATE ANALYSIS; NUMERICAL MODEL; QUESTIONNAIRE SURVEY; REGRESSION ANALYSIS; TEA;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY MASS; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD INTAKE; HAZARD RATIO; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; JAPAN; MALE; NORMAL HUMAN; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; TEA;

ADULT; AGED; CATECHIN; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HEALTH SURVEYS; HEMATOLOGIC NEOPLASMS; HUMANS; JAPAN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; SPAIN; TEA;

ASIA; EURASIA; FAR EAST; JAPAN;

EID: 69949152655     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp187     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev. 2005; 14(4): 925-933. (Pubitemid 40478558)
3. Fernberg P, Odenbro A, Bellocco R, et al. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res. 2007; 67(12):5983-5986. (Pubitemid 46985035)
4. Nieters A, Rohrmann S, Becker N, et al. Smoking and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol. 2008;167(9):10811089. (Pubitemid 351601238)
5. Talamini R, Polesel J, Spina M, et al. The impact of tobacco smoking and alcohol drinking on survival of patients with nonHodgkin lymphoma. Int J Cancer. 2008; 122(7): 1624-1629. (Pubitemid 351294973)
6. Engeland A, Tretli S, Hansen S, et al. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol. 2007; 165(1):44-52. (Pubitemid 46026208)
7. Larsson SC, Wolk A. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer. 2007; 121(7): 1564-1570. (Pubitemid 47328717)
8. Willett EV, Morton LM, Hartge P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008;122(9):2062-2070.
9. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer. 2008;122(6):1418-1421. (Pubitemid 351287244)
10. Descatha A, Jenabian A, Conso F, et al. Occupational exposures and haematological malignancies: overview on human recent data. Cancer Causes Control. 2005;16(8):939-953. (Pubitemid 41191419)
11. Müller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84(1):1-12. (Pubitemid 39625035)
12. Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006; 107(9):2099-2107. (Pubitemid 44665642)
13. Nakatsuka S, Aozasa K. Epidemiology and pathologic features of Hodgkin lymphoma. Int J Hematol. 2006;83(5):391-397. (Pubitemid 44756788)
14. Ahmad N, Feyes DK, Nieminen AL, et al. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl Cancer Inst. 1997;89(24): 1881-1886. (Pubitemid 28009824)
15. Béliveau R, Gingras D. Green tea: prevention and treatment of cancer by nutraceuticals. Lancet. 2004;364(9439): 1021-1022. (Pubitemid 39248651)
16. Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, et al. The antifolate activity of tea catechins. Cancer Res. 2005; 65(6):2059-2064.
17. Cooper R, Morré DJ, Morré DM. Medicinal benefits of green tea: part I. Review of noncancer health benefits. J Altern Complement Med. 2005;11(3):521-528. (Pubitemid 41001422)
18. Cooper R, Morré DJ, Morré DM. Medicinal benefits of green tea: part II. Review of anticancer properties. J Altern Complement Med. 2005;11(4):639-652. (Pubitemid 41279080)
19. kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296(10): 1255-1265.
20. Zaveri NT. Green tea and its polyphenols catechins: medicinal uses in cancer and noncancer applications. Life Sci. 2006; 78(18):2073-2080.
21. Bertolini F, Fusetti L, Rabascio C, et al. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade nonHodgkin's lymphoma. Leukemia. 2000; 14(8): 1477-1482. (Pubitemid 30601356)
22. Lee YK, Bone ND, Strege AK, et al. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood. 2004;104(3): 788-794.
23. Nakazato T, Ito K, Ikeda Y, et al. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res. 2005; 11(16):6040-6049. (Pubitemid 41170336)
24. Noda C, He J, Takano T, et al. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells. Biochem Biophys Res Commun. 2007;362(4):951-957. (Pubitemid 47390666)
25. Annabi B, Currie JC, Moghrabi A, et al. Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leuk Res. 2007;31(9): 1277-1284. (Pubitemid 46873734)
26. Zhang M, Zhao X, Zhang X, et al. Possible protective effect of green tea intake on risk of adult leukaemia. Br J Cancer. 2008; 98(1): 168-170.
27. Frankenfeld CL, Cerhan JR, Cozen W, et al. Dietary flavonoid intake and non-Hodgkin lymphoma risk. Am J Clin Nutr. 2008; 87(5): 1439-1445. (Pubitemid 351679788)
28. Kuo YC, Yu CL, Liu CY, et al. A population-based, casecontrol study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Causes Control. 2009;20(1): 57-65.
29. Tsuji I, Nishino Y, Ohkubo T, et al. A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol. 1998;8(5): 258-263. (Pubitemid 128787379)
30. Tsuji I, Kuwahara A, Nishino Y, et al. Medical cost for disability: a longitudinal observation of national health insurance beneficiaries in Japan. J Am Geriatr Soc. 1999; 47(4):470-476. (Pubitemid 29181374)
31. Kuriyama S, Hozawa A, Ohmori K, et al. Joint impact of health risks on health care charges: 7-year follow-up of National Health Insurance beneficiaries in Japan (the Ohsaki Study). Prev Med. 2004;39(6): 1194-1199. (Pubitemid 39468634)
32. Ogawa K, Tsubono Y, Nishino Y, et al. Validation of a foodfrequency questionnaire for cohort studies in rural Japan. Public Health Nutr. 2003;6(2):147-157. (Pubitemid 36542431)
33. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
34. Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2001.
35. Nishino Y, Tsubono Y, Tsuji I, et al. Japan, Miyagi Prefecture. In: Parkin DM, Whelan SL, Ferlay J, et al, eds. Cancer Incidence in Five Continents. Vol VIII. Lyon, France: International Agency for Research on Cancer; 2002; 260-261, 764, 767. (IARC scientific publication no. 155).
36. Shanafelt TD, Lee YK, Call TG, et al. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. LeukRes. 2006;30(6):707-712.
37. AIDS Surveillance Committee, Ministry of Health, Labour and Welfare. Report of HIV Incidence in Japan, 2006 [in Japanese]. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2007.
38. Knipe DM, Howley PM, Griffin DE, et al, eds. Fields Virology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
39. Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001 ;344(9): 632-636. (Pubitemid 32183578)
40. Koizumi Y, Tsubono Y, Nakaya N, et al. No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol Biomarkers Prev. 2003;12(5):472-473. (Pubitemid 36578489)
41. Suzuki Y, Tsubono Y, Nakaya N, et al. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer. 2004;90(7):1361-1363. (Pubitemid 38586260)
42. Suzuki Y, Tsubono Y, Nakaya N, et al. Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J Epidemiol. 2005;15(4): 118-124. (Pubitemid 41403849)
43. Kikuchi N, Ohmori K, Shimazu T, et al. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer. 2006;95(3):371-373. (Pubitemid 44187600)
44. Li Q, Kakizaki M, Kuriyama S, et al. Green tea consumption and lung cancer risk: the Ohsaki study. Br J Cancer. 2008; 99(7):1179-1184.